INTRODUCTION
Listeria monocytogenes, the causative agent of foodborne listeriosis, is a paradigmatic example of a pathogen exerting tight control over its virulence genes ). This ubiquitous gram-positive bacterium uses a set of nine virulence factors to promote host cell invasion (InlA, InlB), phagosomal escape (hly-encoded LLO, PlcA, and PlcB), rapid cytosolic replication (Hpt), and cell-to-cell spread (ActA, InlC) (Hamon et al., 2006) . Their expression is activated during cell infection (Chatterjee et al., 2006; Shetron-Rama et al., 2002) and depends on PrfA (Mengaud et al., 1991) , a transcription factor of the Crp/Fnr family (Scortti et al., 2007) . PrfA is essential for pathogenesis (Chakraborty et al., 1992) but is equally important for preventing the cost of unneeded virulence factors in the environmental reservoir .
PrfA regulation operates through control of (1) PrfA abundance, exerted at both the transcriptional and translational levels and involving positive autoregulation of the prfA gene, and (2) PrfA activity, via cofactor-mediated allosteric shift between low-(''Off'') and high-(''On'') activity states (reviewed in Scortti et al. [2007] ). The latter is thought to play a key role in the strong PrfA induction observed during intracellular infection . Single amino acid substitutions, called PrfA* mutations, lock PrfA in ''On'' conformation with increased DNA-binding activity (Eiting et al., 2005; Vega et al., 1998) , causing constitutive activation of virulence genes to high, ''infection-like'' levels (Ripio et al., 1997b; Shetron-Rama et al., 2003; Vega et al., 2004) . Recently, a genetic screen in macrophages found that the thiol-redox buffer glutathione (GSH, g-L-Glutamyl-L-cysteinylglycine) (Loi et al., 2015) , endogenously produced by the listerial GshF enzyme (Gopal et al., 2005) , was required to promote PrfA activation (Reniere et al., 2015) . Exogenous GSH had a similar PrfA-inducing effect in vitro in synthetic medium (Portman et al., 2017) . Co-crystallization studies showed that GSH binds in a large tunnel between PrfA's N-terminal and C-terminal domains, priming PrfA for productive interaction with the target DNA (Hall et al., 2016) . While GSH is required for full PrfA induction and intracellular proliferation (Gopal et al., 2005; Reniere et al., 2015) , how GSHdependent PrfA activity is regulated remains to be clarified.
A combination of environmental and endogenous cues converge on PrfA to modulate virulence expression. These include temperature via an RNA thermoswitch that controls prfA translation (Johansson et al., 2002) , stress signals via a SigB-regulated prfA promoter (Nadon et al., 2002) , a reducing environment (Portman et al., 2017) , and metabolic signals, including carbon-source nutrition (Joseph et al., 2008; Milenbachs et al., 1997; Ripio et al., 1997a) or amino acid availability (Haber et al., 2017; Lobel et al., 2015; Xayarath et al., 2009) through as yet not fully understood mechanisms. In addition to the intracellular milieu and GSH, treating the growth medium with activated charcoal also causes strong PrfA induction Milohanic et al., 2003) . This phenomenon is observed (legend continued on next page) in complex media, such as brain-heart infusion (BHI), where PrfAdependent expression is very weak at 37 C. Adsorbent resins, such as Amberlite XAD4, have the same effect, suggesting that the mechanism involves the sequestration of PrfA inhibitory substances .
In this study, we performed a transposon screen to characterize the molecular basis of the intriguing effect of adsorbents on listerial virulence expression. We show that this effect depends on a functional Opp oligopeptide transporter, which allows L. monocytogenes to control PrfA-GSH regulation according to the ''peptide signature'' of the bacterial habitat.
RESULTS
Genetic Screen for Amberlite XAD4 Non-activable Mutants A himar1 transposon (Tn) library was constructed in L. monocytogenes P14-P hly-lux , a wild-type serovar 4b isolate carrying a chromosomally integrated luxABCDE reporter under the control of the PrfA-regulated hly promoter . ''Non-activable'' (PrfA -) Tn mutants were selected in Amberlite XAD4-treated BHI (BHI-Amb) by exploiting the ability of the PrfA-regulated organophosphate permease Hpt to confer susceptibility to the antibiotic fosfomycin (see STAR Methods). Apart from prfA and hpt, two other loci were redundantly targeted upon screening z500 fosfomycin resistant mutants ( Figure 1A ): gshF encoding the listerial GSH synthase, the inactivation of which was previously shown to result in reduced PrfA-dependent expression (Reniere et al., 2015) ; and oppDF encoding the ATPase subunits of the Opp oligopeptide transport system .
The oppD/F::Tn mutants exhibited similar phenotype to the gshF::Tn mutants, characterized by a pleiotropic PrfA-regulated gene activation defect in BHI-Amb as determined using reporter gene tests (Figures S1A-S1C) and promoter activation/gene expression analyses ( Figure 1B ). Knockout mutagenesis of oppD and oppF recapitulated the PrfA -phenotype ( Figure S1D ). Complementation of one of the Tn mutants selected for further characterization (oppF589; Figure 1A ) rescued the parental wild-type PrfA + phenotype ( Figure 1C ). This identified the opp locus as potentially involved in PrfA regulation.
Link between Opp Peptide Transport and PrfA Regulation oppF::Tn (all opp Tn mutants) showed impaired growth in BHI and acquired resistance to bialaphos, a toxic tripeptide that bacteria take up through Opp permeases . Complementation rescued both phenotypes ( Figures  1D and S1E) , confirming that the oppF mutation disabled Opp function. For simplicity, oppF::Tn is henceforth designated as opp (or Opp -) mutant. As expected, opp bacteria showed wild-type growth in chemically defined medium (CDM) only containing free amino acids as proteinogenic N ( Figure 1E , left). Notably, in CDM, the opp mutant also exhibited a PrfA + phenotype equivalent to that of the wild-type parent in BHIAmb ( Figure 1E ), whereas Amberlite XAD4 has no effect on wild-type L. monocytogenes ( Figure S2 ). These data implied that the adsorbent removes some critical Opp-transported BHI component(s), presumably of peptide nature, which affect(s) PrfA regulation.
Since growth in CDM rescued the opp mutant, and a DgshF mutant constructed in P14 exhibited PrfA -phenotype in both CDM and BHI-Amb ( Figure 1E ), gshF is clearly downstream of opp and/or dominant in the PrfA regulation pathway. Transcription analysis excluded that the PrfA -phenotype of the opp mutant in BHI-Amb was due to reduced gshF expression ( Figure 1F ). In addition, overexpression of gshF under the control of a strong promoter (Pd; de la Hoz et al., 2000) ( Figure 1F ) did not reverse the PrfA -phenotype of opp bacteria in BHIAmb, while it successfully complemented the DgshF mutation ( Figure 1G ). However, exogenous addition of 1 mM GSH fully restored the parental PrfA + phenotype in the opp mutant (Figure 1H) . Thus, when Opp function is affected, the limiting factor for PrfA activation does not seem to be the levels of gshF expression but, critically, the amounts of its biosynthetic product, GSH. Overall, these results suggested that an Opp-transported BHI component controls the synthesis or availability of endogenous GSH for PrfA activation. 2B ). We traced the effect to L-cysteine (Cys) ( Figure 2C ). Although Cys is an essential amino acid for L. monocytogenes (Tsai and Hodgson, 2003 ; Figure S3A ), dose-dependent PrfA induction was observed in CDM for both wild-type and opp bacteria once the minimum concentration for eugonic growth (z0.2 mM) had been reached ( Figure S3B ). Since adding Cys to BHI-Amb recapitulated the functional complementation by GSH, and Cys is an essential rate-limiting precursor for GSH biosynthesis (Loi et al., 2015; Lu, 2009) Figure S3AB ) confirmed that both RDGC peptide and free Cys were required for synthesis of the PrfA cofactor, the former in an Opp-dependent manner ( Figure 2E ). In addition to an essential GSH building block, the amino acid Cys could act as a thiol donor (Ohtsu et al., 2010) , potentially contributing to a reducing environment important for PrfA activation (Portman et al., 2017) . (Monnet, 2003; Wouters et al., 2005) . Asterisk indicates p = 0.009 relative to opp mutant in control conditions. See also Figures S3 and S4.
PrfA Repression by Non-Cys-Containing Peptides
We compared the effect of Cys-containing synthetic oligopeptides (Cys-peptides) transported by Opp (RGDC, EVFC, TKPC; Figure S4 ) and versions thereof with Cys replaced by another residue (RGDL, EVFL, TKPR). Regular CDM (0.8 mM Cys) was used to ensure normal growth in the absence of Cys-peptides. While 1 mM Cys-peptide did not alter (or increased) P hly-lux expression, equivalent amounts of the corresponding non-Cyspeptides caused significant Opp-dependent PrfA downregulation (69%-74%, p < 0.001) ( Figure 2F ). TKPR is aka tuftsin, a mamalian immunomodulatory tetrapeptide from the Fc domain of immunoglobulin G (IgG) (Wu et al., 2012) . A listerial derived octapeptide, ASSLLLVG (putative peptide pheromone pPplA; Xayarath et al., 2015) , also caused comparable Opp-dependent repression (88%) ( Figure 2G ). Of three known > 5-mer listerial Opp substrates Whiteley et al., 2017) , two were significantly inhibitory (KLLLLK 96%, SQNPYPIV 59%, RKDVY no effect) ( Figure 2G ). Tripeptides also caused Opp-dependent PrfA downregulation, as illustrated with EVF (truncated derivative of EVFC/L, 81%), ALV (90%) or LLL (3-mer peptide of Leu used to replace the Cys residue in two of the above repressing tetrapeptides, 87%) ( Figure 2H ). A Leu dipeptide caused the same strong inhibition as LLL (93%). However, equivalent molar amounts of free Leu were not inhibitory (p > 0.999), indicating that PrfA repression is specifically linked to the peptide form of the amino acid ( Figure 2H ). Other tested dipeptides showed different degrees of PrfA repressing activity (AF 93%, AL 75%, FV 45%, AG 0%). Overall, our data show that in PrfA-permissive (Cys-replete) conditions, many tested non-Cys peptides, including host-or bacteria-derived peptides, inhibit PrfA.
Balance of Inducing and Inhibitory Peptides Controls PrfA Next, we analyzed the combined effect of PrfA-inducing and inhibitory peptides. In RGDC/RGDL titrations, the Cys-peptide was clearly dominant at all tested RGDL concentrations (Figure 3A) , while maximal inhibition was observed when RGDC was omitted ( Figure 3B ). In contrast, RGDC/LLL titrations resulted in a linear repression response as the LLL concentration increased ( Figure 3C ). These data show that different inhibitory peptides differ in the ability to counteract the PrfA-stimulating effect of Cys-peptides.
We also tested the effect of increasing RGDC concentrations against a fixed ''non-saturating'' amount (0.25 mM) of the strongly repressing Leu di-and tripeptides. Even at the low concentration of 80 mM, the RGDC peptide completely cancelled LL/LLL-mediated repression ( Figures 3D and 3E ). Comparatively larger amounts of free Cys (6.4 mM) were required to achieve the same effect ( Figure 3F ). When 320 mM RGDC or 1 mM GSH were added after several hours of growth in CDM containing limiting Cys (0.1 mM, sufficient to promote growth but not PrfA-dependent expression), the Cys-peptide was again more effective in countering LL/LLL-mediated repression ( Figures 3G and 3H ). Thus, peptide-mediated PrfA inhibition is more efficiently reversed by Cys-peptides than free Cys or, indeed, exogenous GSH, underscoring the importance of Opp in PrfA regulation.
Interestingly, with no differences in the bacterial growth dynamics, a protracted repression was observed with LLL, but not LL, until RGDC, Cys, or GSH exhibited their PrfA-stimulatory effect ( Figures 3D-3H ). This is likely due to release of repressing LL dipeptide intermediate during the metabolic breakdown of LLL into non-repressing free Leu ( Figure 2H ).
Collectively, our results indicate that PrfA induction levels depend on the balance of inhibitory and inducing oligopeptide inputs from the medium, and that the stoichiometry and dynamics of this balance is critically affected by the composition of the peptide mixture.
Opp Is Required for Early PrfA Induction within Host Cells We examined whether the Opp transport system plays any role in intracellular PrfA activation in infected J774 mouse macrophages. An oppDF deletion mutant was used to avoid potential problems of transposon instability in the harsher intracellular conditions. P14DoppDF exhibited PrfA and oligopeptide transport phenotypes indistinguishable from those of the Tn mutants (Figures S1F and S1G). Intracellular PrfA induction, as monitored by actA transcription, was significantly reduced (z60%) in DoppDF at t = 2 h and 4 h compared to wild-type ( Figure 4A ). The induction defect was similar (t = 2 h, p = 0.53), or marginally less pronounced (t = 4 h, p = 0.04), to that of control PrfA activation-deficient DgshF (Reniere et al., 2015) . However, no differences were observed at later stages of intracellular infection (t = 7 h) ( Figure 4A ). These results indicate that Opp is required for early intracellular PrfA activation, presumably by permitting the incorporation of Cys in peptide form according to our in vitro functional data. To further document this, macrophages were deprived of Cys and then pre-treated with the GSHdepleting drug buthionine sulfoximine (BSO) (Reniere et al., 2015; Rouzer et al., 1981) to minimize the potential input of host cell-derived free Cys and GSH pools. In these conditions, DoppDF exhibited the same actA induction defect at t = 4, while no significant changes were observed for the wild-type (Figure 4B) , consistent with the PrfA activation deficit being attributable to defective import of Cys-containing peptides.
Nutritional versus PrfA Regulatory Roles of Opp in Virulence
Experiments with DoppDF show that listerial Opp is required for efficient growth in macrophages ( Figure 4C ) and full virulence in a mouse model of systemic infection ( Figure S5 ). This could result from either defective activation of the PrfA virulence regulon (Figure 4A ), or defective growth due to impaired utilization of host-derived peptides ( Figures 1D, 2B , and 2D, right). To dissect this, we analyzed the intracellular phenotype of DoppDF with PrfA regulation bypassed using a prfA* G145S allele ( Figure 4D ). prfA* G145S bacteria overexpress the PrfA regulon without the need of adding adsorbents to the BHI Ripio et al., 1996 Ripio et al., , 1997b , independently or gshF/GSH (Reniere et al., 2015) , and are largely unsusceptible to peptidemediated regulation ( Figure S6 ). Growth of prfA*DoppDF was still strongly affected ( Figure 4E ), indicating that peptides are used as the main amino acid source intracellularly, consistent with previous data using auxotrophic mutants (Marquis et al., 1993) .
To assess the impact of Opp-dependent PrfA activation, we compared the intracellular dynamics of DoppDF expressing wild-type PrfA (PrfA WT ), which necessitates activation to promote infection , or constitutively activated PrfA*. Because the strong nutritionally related proliferation defect caused by the Opp -mutation could mask PrfArelated effects (see DoppDF bacteria in Figures 4C and 4E ), we used a competition assay to enhance discrimination. No differences in competitive ability were observed between PrfA WT -and PrfA*-expressing Opp-proficient bacteria, confirming that the levels of virulence gene activation are in both cases similar ( Figure 4F, left) . In contrast, when Opp was absent, PrfA WT bacteria (requiring Opp for efficient PrfA activation; Figure 4A ) were outcompeted by those with constitutively activated PrfA* ( Figure 4F, right) . Overall, these data identify Opp as an important listerial virulence determinant with key dual roles in N nutrition and PrfA activation within host cells.
Peptide-Mediated Regulation Is Due to Changes in PrfA Activity
To explore the mechanism behind PrfA regulation by peptides, we examined the correlation between PrfA-dependent expression and PrfA protein abundance in activating and inhibiting conditions. Since PrfA positively autoregulates its own gene (Mengaud et al., 1991) (Figure 5A ), variations in PrfA activity also affect PrfA concentration (Vega et al., 1998) . This problem was circumvented by disrupting the transcriptional positive feedback loop (strain P14prfA mc ; Figure 5A ). Even without PrfA autoregulation, P14prfA mc showed the expected PrfA induction patterns under strongly upregulating (CDM medium supplemented with extra Cys, Cys-peptide or GSH) or downregulating (addition of repressor peptide, growth in BHI) conditions (Figure 5B) . Despite the widely different expression levels, no concomitant changes in PrfA abundance were observed by western immunoblotting ( Figure 5C ). Thus, PrfA regulation by peptides is primarily exerted via control of PrfA protein activity, not prfA gene expression.
Mechanism of Peptide-Mediated PrfA Inhibition
While the effect of Cys/Cys-peptides is explained by their essential role in the synthesis of the PrfA cofactor GSH, different mechanisms may underlie peptide-mediated inhibition of PrfA activity. We tested the simplest scenario, i.e., direct binding to PrfA. Weak, albeit reproducible, increases in the melting temperature (T m ) of purified PrfA, indicative of potential ligand-mediated protein stabilization, were observed for the strongly repressing LL and LLL peptides in thermal shift assays (Renaud et al., 2016) ( Figures S7A and S7B ). Isothermal titration calorimetry (ITC) assays (Renaud et al., 2016) demonstrated that both peptides have high affinity for PrfA (K d z25 mM), while no binding was detected for the non-inhibitory free Leu ( Figure S7C ). Biolayer interferometry assays (Citartan et al., 2013 ) using a biotinylated oligonucleotide containing the PrfA box of the PplcA/Phly promoters demonstrated that the Leu peptides, but not free Leu, strongly inhibit PrfA-DNA binding ( Figure 6 ). Structural evidence for the inhibitory mechanism was obtained through co-crystallization of PrfA with the LL dipeptide. The asymmetric unit of the PrfA-LL complex determined at 2.7 Å resolution contained a biological dimer identical to the previously solved PrfA WT structure (Eiting et al., 2005) (Figure 7A , top). Difference Fourier and Polder electron density maps confirmed the binding of the LL peptide to monomer A only (Figures S7D-S7F ; Table S1 ), as recently seen with synthetic PrfA inhibitors based on ring-fused 2-pyridones (Good et al., 2016) . LL is positioned within the interdomain tunnel through hydrogen bonds with the peptide backbone ( Figures 7A and 7B ). This tunnel was recently identified as the binding site for the GSH cofactor (Hall et al., 2016) (Figure 7A , bottom) and the ring-fused 2-pyridone inhibitory ligands (Good et al., 2016; Kulé n et al., 2018) . In the PrfA-GSH complex, the backbone torsion angles of the GSH tripeptide are in an extended b strand conformation leading to five main-chain contacts with strands b5 and the turn connecting to b6 (Hall et al., 2016) . Combined, these interactions result in the partial collapse of the interdomain tunnel and the positioning of aE from PrfA's helix-turn-helix (HTH) motif for productive DNA binding (Eiting et al., 2005; Hall et al., 2016) ( Figure 7A ). Interestingly, the LL peptide is also in an extended conformation and establishes two of the five main-chain contacts made by GSH to b5 (residues Met58-Lys64) ( Figure 7B ). Despite this and the fact that the side chain of Leu2 occupies the same hydrophobic pocket as the thiol group of the GSH molecule (Hall et al., 2016) , wedged between the aromatic residues Phe67 and Tyr126, the position of Leu1 is unique and prevents the collapse of the tunnel needed for PrfA activation. In particular, the 5 Å movement of Tyr154 involved in the intricate network of water-mediated hydrogen bonds connecting the glycine of GSH with Ser177 in the HTH motif (Hall et al., 2016) is sterically hindered by the Leu1 side chain ( Figure 7C ). Since, in contrast to the LL peptide, GSH has weak affinity for PrfA (K d z4 mM, Reniere et al., 2015 ; undetectable by ITC), our data suggest that the mechanism of peptide-mediated PrfA inhibition involves, at least for some peptides, competitive occupancy of the GSH binding site.
DISCUSSION
Virulence factors are essential for pathogenesis but a fitness burden in non-infection conditions . Pathogens manage this dichotomy through virulence gene regulators, but how they sense the transition into a propitious host habitat remains less well characterized. In this study, we report an environmental regulation mechanism by which L. monocytogenes controls the activity of its master virulence switch, PrfA, through the balance of antagonistic effects of inducing and inhibitory peptides scavenged from the medium. Our findings uncover a hitherto undescribed mechanism of direct regulation of a bacterial transcription factor via the oligopeptide composition of the habitat.
Inducing peptides provide Cys residue, which we show is essential for PrfA activation through its key role as rate-limiting GSH precursor (Loi et al., 2015; Lu, 2009 ). Our results show that PrfA is regulated by the levels of Cys/Cys-peptides in the medium, thus effectively linking the PrfA-GSH system to the environmental conditions. The observed dissociation between the nutritional role of Cys/Cys-peptides and virulence gene activation ( Figure S3 ) is consistent with Cys/Cys-peptides acting as bona fide PrfA regulatory signals.
PrfA activation by Cys/Cys-peptides is antagonized by oligopeptides lacking Cys. Based on our data, an abundance of inhibitory peptides explains the weak PrfA-dependent expression levels typically observed in BHI and other complex media (Ripio et al., , 1997b . Although not a requirement, Leu residues were present in strongly repressing peptides. This was also recently noted by Portman et al. (2017) , who independently observed that peptides in the listerial growth medium generally inhibited PrfA. These authors attributed the effect of Leucontaining peptides to inhibition of CodY-mediated prfA gene activation (Lobel et al., 2015) in response to either increasing concentrations of branched-chain amino acids (BCAAs) or stringent response dampening upon addition of peptides (Portman et al., 2017) . However, our data show that free Leu does not inhibit PrfA (Figure 2H ), while the relatively elevated amounts of BCAAs and other amino acids in CDM (in the mM range) are unlikely to trigger a starvation response. Moreover, our experiments with the P14prfA mc construct ( Figure 5A ), which includes the regulatory region targeted by CodY (Lobel et al., 2015) , show that the effects of peptides are not due to changes in prfA expression but in PrfA protein activity ( Figures 5B and 5C ). This leaves two possible explanations for the repression mechanism:
(1) inhibition via unknown interposed factors or (2) direct interaction with PrfA. We documented the latter through biophysical studies and co-crystallization of PrfA with inhibitory Leu dipeptide, which located the ligand to the GSH binding site in PrfA's interdomain tunnel. Strikingly, L-leucylleucine adopts the same PrfA protein amounts only depend on the expression/translation levels of the non-PrfA-regulated monocistronic prfA message (reviewed in Scortti et al. [2007] extended conformation and position as the g-glutamylcysteinylglycine tripeptide (Hall et al., 2016) , making similar mainchain contacts with PrfA residues ( Figure 7B ). This is reminiscent of the sequence-independent binding mechanism of the OppA/AppA/DppA receptor proteins of ABC oligopeptide transport systems (Monnet, 2003) . The peptide is similarly buried in a cavity between two large protein lobes ( Figure 7A ), anchored via electrostatic contacts with the invariant a-linked peptide backbone while large water-filled pockets easily accommodate diverse side chains, imposing little binding specificity (Berntsson et al., 2009; Levdikov et al., 2005) . The LL/LLL peptides bind to PrfA with mM affinity comparable to that of the ligands accepted by OppA-type peptide-binding proteins (Li et al., 2015) . The PrfA interdomain tunnel is spacious enough to accommodate four/six-mer peptides or longer if overhanging outside PrfA. A surface lined with abundant hydrophobic amino acids and also polar groups affords flexible side-chain docking potential, consistent with the ability of peptides of different polarity and composition to cause PrfA inhibition.
Our data provide a working model where the unique set of conformational changes specifically triggered by GSH is hindered by non-specific blockade of PrfA's GSH binding site by peptides. While activation requires occupancy of the two GSH sites of the PrfA dimer (Hall et al., 2016) , non-specific peptide binding to only one monomer ( Figure 7A ) suffices to alter the correct symmetry of the two HTH motifs, preventing DNA-binding and virulence gene expression. Further work remains to fully characterize the mechanism and dynamics of promiscuous inhibition of PrfA by imported peptides and intermediate breakdown products during their metabolic processing ( Figure S8 ).
Free amino acids are found at low concentrations in soil (z0.01 to 0.15 mM), whereas oligopeptides are the main organic N source for microbial growth in the environment (Broughton et al., 2015; Farrell et al., 2013) . Because Cys is considerably less abundant in proteins compared to other amino acids, soil oligopeptides could be critical, together with other PrfA-repressing environmental signals (temperature % 30 C, plant-derived b-glucosides and other phosphotransferase system (PTS)-transported sugars; de las Heras et al., 2011) in preventing wasteful production of virulence factors outside the host ( Figure S8 ). How then to explain the strong PrfA induction in the peptide-rich cytosol? Interestingly, the Cys content is significantly higher in mammalian proteins (2.3%) than in bacterial or plant proteins (0.5%-1%) (Miseta and Csutora, 2000) , which are the main source of organic N in natural ecosystems. These differences may be sufficient to shift the balance of inducing/inhibitory effects of peptides toward PrfA upregulation. Specific cysteine-rich proteins from the host may provide a unique source of PrfA-activating peptides. An example is the Cys-rich miniproteins, which include the chemokines and defensins, secreted by phagocytes or present in cells typically targeted by L. monocytogenes, such as macrophages, dendritic cells, and epithelial cells (Lavergne et al., 2012) . Adding a layer of complexity, mammalian immunomodulatory peptides may also also cause PrfA inhibition, as illustrated here with the IgG-derived prophagocytic tetrapeptide tuftsin (TKPR) (Wu et al., 2012) (Figure 2F ), potentially contributing to virulence fine-tuning during infection. Finally, self-produced and other microbially derived peptides, exemplified by the PplA peptide (ASSLLLVG, Figure 2G ), may allow coordinating PrfA regulation according to population density or microbiome conditions ( Figure S8 ).
Based on our in vitro functional data, the significantly reduced actA induction in Opp -L. monocytogenes within macrophages at early/mid time points of infection -comparable to that of the DgshF mutant-suggests that Cys-peptides contribute to PrfA-GSH system upregulation upon host cell invasion. Although GSH is present intracellularly at high concentrations (1-10 mM) (Banerjee, 2012; Lu, 2009) , the GshF dependence of PrfA induction within macrophages (Reniere et al., 2015) (Figure 4A ) argues against listerial uptake of host-cell GSH having a main contribution. Free Cys is also unlikely to be sufficient to promote PrfA activation because its intracellular concentrations are normally kept at low (mM), limiting steady-state levels due to its cytotoxicity (Banerjee, 2012; Ohtsu et al., 2010) . Interestingly, Opp became progressively dispensable for PrfA activation while the GshF dependence was maintained throughout the infection time course (Figure 4A ). Since L. monocytogenes is virtually auxotrophic to Cys (Tsai and Hodgson, 2003) ( Figure 2D , right), de novo bacterial synthesis of GSH obviously depends on an external Cys source. Prolonged infection may lead to gradual depletion of Opp-transported oligopeptides, resulting in critical alteration of the Cys-providing (inducing)/non-Cys-containing (inhibitory) peptide balance, only necessitating the input of relatively minor amounts of free Cys for PrfA induction. Alternatively, other listerial transporters (e.g., dipeptide transporters) may take over the role of Opp in Cys-peptide import, or additional (co)factors may contribute to PrfA activation under Cys/ Cys-peptide (GSH)-limiting conditions. The reported data support a model in which PrfA activity is antagonistically modulated by activating and inhibitory nutritional peptides, with the Opp transport system as a key player upstream of GshF in the PrfA regulation hierarchy ( Figure S8 ). This model reconciles the essentiality of GshF/GSH for PrfA activation (Reniere et al., 2015; Portman et al., 2017) with most known features of listerial virulence regulation, including the contrasting PrfA phenotypes in complex (Ripio et al., , 1997b versus chemically defined media (Bohne et al., 1994) or the intriguing ''charcoal'' effect Ermolaeva et al., 2004) . The model provides a unifying framework to interpret how the facultative pathogen L. monocytogenes senses niche transitions and adjusts virulence gene expression accordingly.
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Received: September 7, 2018 Revised: November 9, 2018 Accepted: January 17, 2019 Published: February 12, 2019 EXPERIMENTAL MODEL AND SUBJECT DETAILS Bacteria, plasmids, culture conditions, chemicals The strains and plasmids used in this study are shown in Table S2 . Listeria were routinely grown in porcine BHI (BD-Difco) and Escherichia coli in Luria-Bertani (LB) media, with 1% agar for solid cultures. For adsorbent-treated BHI agar, 1% (w/v) Amberlite XAD4 resin (Sigma-Aldrich) or 0.5% (w/v) activated charcoal powder (Merck) was added to the medium prior to autoclaving. For fluid Amberlite XAD4-treated BHI cultures (BHI-Amb), the resin was aseptically removed after autoclaving to avoid interference with optical density (OD) readings. Chemically defined CDM is a modification of the improved minimal medium (IMM) of Phan-Thanh and Gormon (1997) , with the following composition: 6.56 g/L KH 2 OP 4 , 30.96 g/L NaHPO 4 7H 2 O, 0.41 g/L MgSO 4 , 88 mg/L ferric citrate, 0.1 g/L each of the (L-) amino acids leucine, isoleucine, valine, methionine, arginine, cysteine, histidine and tryptophan, 0.6 g/L L-glutamine, 2.5 mg/L adenine, 0.5 mg/L biotin, 5 mg/L riboflavin, 1 mg/L each of thiamine, pyridoxal, para-aminobenzoic acid, calcium panthothenate and nicotinamide, 5 mg/L thioctic acid and 4.5 g/L glucose. CDM was used freshly prepared from filter-sterilized stock solutions stored at 4 C (except cysteine, glutamine, biotin and ferric citrate solutions, kept at -20 C; and phosphates, MgSO 4 and glucose, at room temperature). Antibiotic supplements (mg/mL) were as follows (lower values for Listeria, others for E. coli or both): erythromycin 5 or 250, chloramphenicol 7.5 or 20, spectinomycin 100, carbenicillin 100. All incubations were carried out at 37 C, with 180 rpm orbital shaking for fluid cultures, unless stated otherwise. GSH was kept in reduced state with 2 mM Tris[2-carboxyethyl]phosphine hydrochloride (TCEP) in the stock solution. Chemicals and oligonucleotides were from Sigma-Aldrich unless otherwise indicated.
Cell culture Low passage J774A.1 cells, a female murine macrophage cell line, were maintained in a humidified incubator at 37 C and 5% CO 2 in DMEM (GIBCO) without antibiotics supplemented with 10% FBS (GIBCO).
Mice
Experiments were covered by a Project License granted by the UK Home Office under the 1986 Animals (Scientific Procedures). The Roslin Institute Ethical Review Committee approved this license and the experiments (Project A933). Female, six weeks old BALB/c mice were purchased from Charles River. Mice were group-housed in Level 2 SPF barrier facility at the Roslin Institute, University of Edinburgh (UK), and feed a regular chow diet ad libitum.
METHOD DETAILS
General DNA techniques PCR was performed with GoTaq DNA polymerase (Promega) for general purposes or high-fidelity PfuUltra II Fusion HS (Agilent) for gene constructs or sequence validation. Plasmid and PCR DNA was purified with QIAprep Plasmid Mini kit and QIAquick PCR purification kit, respectively (QIAGEN). Plasmids were introduced into L. monocytogenes by electroporation using a Gene Pulser Xcell apparatus (Bio-Rad) and into E. coli by chemical transformation. Restriction enzymes were used according to the manufacturer's instructions (New England Biolabs). DNA sequences were determined using the Sanger method at Source BioScience (Livingston, UK).
Transposon library and screening A random insertion library was constructed in P14-P hly-lux (wild-type L. monocytogenes P14 complemented with a PrfA-regulated bioluminescent gene reporter in the integrative plasmid pPL2lux-P hlyA ) by himar1 transposon mutagenesis using plasmid pJZ037 (Zemansky et al., 2009 ). For direct isolation of transposon mutants unable to express PrfA-dependent genes in BHIAmb, we used the PrfA-regulated virulence gene hpt as a ''natural'' negative selection marker. hpt encodes a sugar phosphate (organophosphate) permease that promotes rapid bacterial replication in the host cytosol but which also transports fosfomycin, rendering L. monocytogenes susceptible to the antibiotic when PrfA is induced . Selection was performed in 150 mg/ml fosfomycin (MIC for P14 in BHIA-Amb z12-32 mg/ml) and resistant clones subjected to phenotypic screening and PCR analysis to exclude Tn insertions in hpt or prfA. The prfA gene was also sequenced in all PrfA -mutants with correct PCR patterns for presence of non-synonymous point mutations. Transposition mapping was by colony PCR using relevant oligonucleotides (Table  S3) .
Genetic constructs
Oligonucleotides used to generate PCR fragments for cloning contained suitable restriction site extensions at their 5 0 end (Table S3 ). Complementations were carried out using the pAT29 bifunctional vector with spectinomycin selection (Trieu-Cuot et al., 1990) , compatible with the erythromycin resistance marker of the transposable element. For complementation of oppF::Tn, the oppF gene with its native promoter (P oppF , Figure 1A ) was PCR-amplified from strain P14 with oligonucleotide primers 21 and 22 and inserted into pAT29's multicloning site (MCS) (plasmid pAToppF PoppF ). oppF was also placed under the control of the oppA-F operon promoter (P opp ) ( Figure 1A ) by inserting the corresponding region, amplified using primers 19 and 20, in the adequate orientation into pAToppF PoppF (plasmid pAToppF Popp ). gshF was overexpressed from pAT29 by inserting into the vector's MCS a PCR segment containing the strong gram-positive promoter Pd from the streptococcal pSM19035 plasmid partitioning gene d (de la Hoz et al., 2000) , flanked by SalI and BanHI restriction sites, followed by the gshF gene amplified from P14 with primers 25 and 26 (plasmid pATgshF
QUANTIFICATION AND STATISTICAL ANALYSIS
Statistical analyses were performed using GraphPad Prism software. Data with single comparisons were analyzed using two-tailed t test. Data with multiple comparisons were assessed using one-way or two-way ANOVA tests with the appropriate post hoc comparisons, with only relevant comparisons noted on the figures. Figure legends include the exact number of replicates for each experiment and the specific statistical analysis.
DATA AVAILABILITY
The atomic coordinates and structure factors for the PrfA-LL peptide complex have been deposited in the Protein Data Bank under the ID code PDB: 6HCK.
